The triglyceride glucose-body mass index: a non-invasive index that identifies non-alcoholic fatty liver disease in the general Japanese population

被引:30
|
作者
Hu, Haofei [1 ,2 ,5 ]
Han, Yong [3 ,4 ,5 ]
Cao, Changchun [6 ]
He, Yongcheng [7 ]
机构
[1] Shenzhen Univ, Affiliated Hosp 1, Dept Nephrol, Shenzhen 518000, Guangdong, Peoples R China
[2] Shenzhen Second Peoples Hosp, Dept Nephrol, Shenzhen 518000, Guangdong, Peoples R China
[3] Shenzhen Second Peoples Hosp, Dept Emergency, Shenzhen 518000, Guangdong, Peoples R China
[4] Shenzhen Univ, Affiliated Hosp 1, Dept Emergency, Shenzhen 518000, Guangdong, Peoples R China
[5] Shenzhen Univ, Hlth Sci Ctr, Shenzhen 518071, Guangdong, Peoples R China
[6] Shenzhen Dapeng New Dist Nanao Peoples Hosp, Dept Rehabil, 6,Renmin Rd, Shenzhen 518000, Guangdong, Peoples R China
[7] Shenzhen Hengsheng Hosp, Dept Nephrol, 20 Yintian Rd, Shenzhen 518000, Guangdong, Peoples R China
关键词
Non-alcoholic fatty liver disease; Triglyceride glucose-body mass index; Negative predictive value; Receiver operating characteristic; Positive predictive value; ULTRASOUND HEPATIC/RENAL RATIO; AMERICAN ASSOCIATION; INSULIN-RESISTANCE; METABOLIC SYNDROME; ATTENUATION RATE; DIAGNOSIS; STEATOSIS; LIPOTOXICITY; ELASTOGRAPHY; VALIDATION;
D O I
10.1186/s12967-022-03611-4
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background By identifying individuals at high risk for non-alcoholic fatty liver disease (NAFLD), interventional programs could be targeted more effectively. Some studies have demonstrated that triglyceride glucose-body mass index (TyG-BMI) showed an independent positive association with NAFLD. However, research on its diagnostic value in patients with suspected NAFLD is limited. In this study, we aimed to evaluate whether TyG-BMI was accurate in detecting NAFLD in the general Japanese population. Methods A cross-sectional study of 14,280 individuals who underwent a comprehensive health examination was conducted. Standard protocols were followed to collect anthropometric measurements, lab data, and ultrasonography features. All participants were randomly stratified into the development group (n = 7118) and validation group (n = 7162). The TyG-BMI was calculated. Following this, the diagnostic value of the TyG-BMI was evaluated based on the area under the receiver-operating characteristic curve (AUROC). Two cutoff points were selected and used to rule out or rule in the NALFD, and the specificity, sensitivity, negative predictive value, and positive predictive value were explored, respectively. In order to verify the stability of the results, external verification was performed. Results There were 1272 and 1243 NAFLD participants in the development and validation groups, respectively. The area under the ROC curve (AUC) of TyG-BMI was 0.888 (95% CI 0.876-0.896) and 0.884 (95% CI 0.875-0.894) for the training and validation group, respectively. Using the low TyG-BMI (182.2) cutoff, NAFLD could be excluded with high accuracy (negative predictive value: 96.9% in estimation and 96.9% in validation). The presence of NAFLD could effectively be determined by applying the high cutoff of TyG-BMI (224.0), as the positive predictive value of the estimation and validation groups is 70.7% and 70.1%, respectively. As a result of applying this model, 9996 (70%) of the 14,280 participants would not have undergone ultrasonography, with an accurate prediction of 9308 (93.1%). AUC was 0.874 for external validation using 183,730 Chinese non-obese participants. TyG-BMI was demonstrated to be an excellent diagnostic tool by both internal and external validation. Conclusions In conclusion, the present study developed and validated a simple, non-invasive, and cost-effective tool to accurately separate participants with and without NAFLD in the Japanese population, rendering ultrasonography for identifying NAFLD unnecessary in a substantial proportion of people.
引用
收藏
页数:18
相关论文
共 50 条
  • [31] Non-invasive assessment of liver steatosis in non-alcoholic fatty liver disease
    Kan, Hiromi
    Kimura, Yuki
    Hyogo, Hideyuki
    Fukuhara, Takayuki
    Fujino, Hatsue
    Naeshiro, Noriaki
    Honda, Yohji
    Kawaoka, Tomokazu
    Tsuge, Masataka
    Hiramatsu, Akira
    Imamura, Michio
    Kawakami, Yoshiiku
    Aikata, Hiroshi
    Ochi, Hidenori
    Arihiro, Koji
    Chayama, Kazuaki
    HEPATOLOGY RESEARCH, 2014, 44 (14) : E420 - E427
  • [32] Non-invasive fibrosis assessment in non-alcoholic fatty liver disease
    Rios, Rafael S.
    Zheng, Kenneth I.
    Targher, Giovanni
    Byrne, Christopher D.
    Zheng, Ming-Hua
    CHINESE MEDICAL JOURNAL, 2020, 133 (22) : 2743 - 2745
  • [33] Non-invasive prediction of fibrosis in non-alcoholic fatty liver disease
    Dogru, Teoman
    Genc, Halil
    Ercin, Cemal Nuri
    Tapan, Serkan
    JOURNAL OF HEPATOLOGY, 2011, 55 (02) : 498 - 499
  • [34] Non-invasive Diagnosis of Fibrosis in Non-alcoholic Fatty Liver Disease
    Arora, Anil
    Sharma, Praveen
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2012, 2 (02) : 145 - 155
  • [35] Non-Invasive Diagnostic Tests for Non-Alcoholic Fatty Liver Disease
    Estep, J. M.
    Birerdinc, A.
    Younossi, Z.
    CURRENT MOLECULAR MEDICINE, 2010, 10 (02) : 166 - 172
  • [36] Validation of the Fatty Liver Index for identifying non-alcoholic fatty liver disease in a Kenyan population
    Lajeunesse-Trempe, Fannie
    Boit, Michael K.
    Kaduka, Lydia U.
    De Lucia-Rolfe, Emanuella
    Baass, Alexis
    Paquette, Martine
    Piche, Marie-Eve
    Tchernof, Andre
    Christensen, Dirk L.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2023, 28 (10) : 830 - 838
  • [37] Non-invasive fibrosis assessment in non-alcoholic fatty liver disease
    S. Rios Rafael
    I Zheng Kenneth
    Targher Giovanni
    Byrne Christopher D.
    Zheng Ming-Hua
    中华医学杂志英文版, 2020, 133 (22) : 2743 - 2745
  • [38] NON-INVASIVE CHARACTERISATION OF NON-ALCOHOLIC FATTY LIVER DISEASE BY MRI
    Lavin-Plaza, B.
    Jaubert, O.
    Prieto, C.
    Phinikaridou, A.
    Botnar, R.
    ATHEROSCLEROSIS, 2020, 315 : E46 - E46
  • [39] Non-invasive diagnosis and staging of non-alcoholic fatty liver disease
    Kechagias, Stergios
    Ekstedt, Mattias
    Simonsson, Christian
    Nasr, Patrik
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2022, 21 (03): : 349 - 368
  • [40] Diagnosis of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Non-invasive tests are enough
    Castera, Laurent
    LIVER INTERNATIONAL, 2018, 38 : 67 - 70